Platinum Industries Ltd (PLATIND.NS)
INR 255.3
(1.27%)
INR 255.3
(1.27%)
| Breakdown | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 2.64 Billion | 2.31 Billion | 1.87 Billion | 891.41 Million |
| Cost of Revenue | 1.62 Billion | 1.51 Billion | 1.44 Billion | 754.24 Million |
| Gross Profit | 1.01 Billion | 801.38 Million | 436.59 Million | 137.17 Million |
| Operating Expenses | 164.2 Million | 279.43 Million | 192.06 Million | 69.31 Million |
| Selling, General and Administrative Expenses | 137.1 Million | 279.43 Million | 192.06 Million | 69.31 Million |
| Research and Development Expenses | 27.1 Million | - | - | - |
| Other Expenses | - | - | - | - |
| Cost and Expenses | 1.78 Billion | 1.79 Billion | 1.63 Billion | 823.55 Million |
| Operating Income | 854.47 Million | 521.95 Million | 244.53 Million | 67.86 Million |
| Interest Expense | 23.69 Million | 19.85 Million | 12.36 Million | 2.76 Million |
| Income Tax Expense | 149.02 Million | 133.52 Million | 62.12 Million | 18.8 Million |
| Earnings before Tax | 584.04 Million | 509.36 Million | 239.6 Million | 66.95 Million |
| Net Income | 437.29 Million | 379.05 Million | 177.47 Million | 48.15 Million |
| Earnings Per Share Basic | 10.55 | 9.42 | 4.41 | 1.20 |
| Earnings Per Share Diluted | 10.55 | 9.42 | 4.41 | 1.20 |
| Weighted Average Shares Outstanding | 41.45 Million | 40.25 Million | 40.25 Million | 40.25 Million |
| Weighted Average Shares Outstanding (Diluted) | 41.45 Million | 40.25 Million | 40.25 Million | 40.25 Million |
| Gross Margin | 0.39 | 0.35 | 0.23 | 0.15 |
| EBIT Margin | 0.22 | 0.23 | 0.13 | 0.08 |
| Profit Margin | 0.17 | 0.16 | 0.09 | 0.05 |
| EBITDA | 594.06 Million | 547.48 Million | 249.62 Million | 77.15 Million |
| Earnings Before Tax Margin | 0.32 | 0.23 | 0.13 | 0.08 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 1.02 Billion | 803.51 Million | 2.64 Billion | 612.21 Million | 609.05 Million | 619.16 Million |
| Cost of Revenue | 686.99 Million | 561.74 Million | 1.76 Billion | 410.71 Million | 392.56 Million | 396.18 Million |
| Gross Profit | 339.56 Million | 241.77 Million | 882.75 Million | 201.5 Million | 216.49 Million | 222.98 Million |
| Operating Expenses | 39.94 Million | 98.35 Million | 300.9 Million | 72.41 Million | 61.98 Million | 68.16 Million |
| Selling, General and Administrative Expenses | 39.94 Million | 98.35 Million | - | 72.41 Million | 61.98 Million | 68.16 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 726.93 Million | 660.09 Million | 2.06 Billion | 483.12 Million | 454.54 Million | 464.34 Million |
| Operating Income | 299.62 Million | 143.42 Million | 581.85 Million | 129.09 Million | 154.51 Million | 154.82 Million |
| Interest Expense | 4.2 Million | 1.93 Million | 23.69 Million | 5.74 Million | 8.45 Million | 7.56 Million |
| Income Tax Expense | 61.59 Million | 42.98 Million | 149.02 Million | 31.96 Million | 37.21 Million | 36.87 Million |
| Earnings before Tax | 238.97 Million | 150.07 Million | 584.04 Million | 131.53 Million | 151.62 Million | 150.82 Million |
| Net Income | 175.17 Million | 106.19 Million | 437.29 Million | 100.47 Million | 115.69 Million | 114.93 Million |
| Earnings Per Share Basic | 3.19 | 2.36 | - | 1.83 | 2.87 | 2.86 |
| Earnings Per Share Diluted | 3.19 | 2.36 | - | 1.83 | 2.87 | 2.86 |
| Weighted Average Shares Outstanding | 54.91 Million | 44.99 Million | 41.44 Million | 54.92 Million | 40.25 Million | 40.25 Million |
| Weighted Average Shares Outstanding (Diluted) | 54.91 Million | 44.99 Million | 41.44 Million | 54.92 Million | 40.25 Million | 40.25 Million |
| Gross Margin | 0.33 | 0.30 | 0.33 | 0.33 | 0.36 | 0.36 |
| EBIT Margin | 0.20 | 0.19 | - | 0.22 | 0.27 | 0.26 |
| Profit Margin | 0.17 | 0.13 | 0.17 | 0.16 | 0.19 | 0.19 |
| EBITDA | 203.51 Million | 151.07 Million | - | 136.15 Million | 161.88 Million | 161.9 Million |
| Earnings Before Tax Margin | 0.29 | 0.18 | 0.22 | 0.21 | 0.25 | 0.25 |
RWL
CIZN
HL-PB
BACTIQ
SGMNF
TIDE